Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Feiyanqinghuafang is a Traditional Chinese Medicine (TCM) herbal formula primarily investigated for the treatment of severe pneumonia. It is strongly associated with Qingfei Paidu Tang, a multi-ingredient decoction that gained significant attention and widespread use in China for treating various types of pneumonia, including COVID-19. The formula is composed of 21 different herbs and is believed to exert its therapeutic effects through a multi-target approach, including immune regulation, anti-inflammatory actions, organ protection, and potentially antiviral activities. It aims to clear heat, detoxify, resolve dampness, and harmonize qi, thereby improving symptoms, shortening recovery time, and preventing disease progression.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Feiyanqinghuafang.